Innovation and Equity in an Age of Gene Editing
By Charis Thompson, Ruha Benjamin, Jessica Cussins and Marcy Darnovsky,
The Guardian
| 05. 19. 2015
The first day of BEINGS2015, “A Gathering of Global Thought Leaders to Reach Consensus on the Direction of Biotechnology for the 21st Century”, in Atlanta, coincided with the announcement by the National Academy of Science and National Academy of Medicine of an initiative to look into “promising new treatments for disease,” given that “recent experiments to attempt to edit human genes also have raised important questions about the potential risks and ethical concerns of altering the human germline.”
It is the time of prizes and tussles over intellectual property and experiments on non-viable human embryos, and, calls for caution from CRISPR-CAS9 scientists (here and here and here). Also still in the air is the UK’s political vote, despite an EU consensus against germline genetic modification (was this the first step of ‘Brexit’?) to allow clinics to apply for permission to undertake IVF with mitochondrial DNA donation, a form of germ cell genetic modification that requires egg donation. These technologies are widely considered threshold technologies with unknown and irreversible consequences for individuals, humanity and the environment.
During...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Justin McCurry, The Guardian | 04.01.2024
A Chinese scientist who was imprisoned for his role in creating the world’s first genetically edited babies says he has returned to his laboratory to work on the treatment of Alzheimer’s and other genetic diseases.
In an interview with a...
By Billy Perrigo, TIME | 03.11.2024
The U.S. government must move “quickly and decisively” to avert substantial national security risks stemming from artificial intelligence (AI) which could, in the worst case, cause an “extinction-level threat to the human species,” says a report commissioned by the U.S...